{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:20:20Z","timestamp":1775251220570,"version":"3.50.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1997,7,1]],"date-time":"1997-07-01T00:00:00Z","timestamp":867715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1997,7,1]],"date-time":"1997-07-01T00:00:00Z","timestamp":867715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[1997,7,1]]},"DOI":"10.1038\/eye.1997.126","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T08:14:32Z","timestamp":1309767272000},"page":"453-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["A comparative approach to topical cyclosporine therapy"],"prefix":"10.1038","volume":"11","author":[{"given":"David L","family":"Williams","sequence":"first","affiliation":[]}],"member":"297","reference":[{"key":"BFeye1997126_CR1","unstructured":"Borel JF . Cyclosporine: historical perspectives. In: Kahan BD, editor. First international congress on cyclosporine. Orlando: Grune & Stratton, 1984: 3\u201313."},{"key":"BFeye1997126_CR2","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/BF01973261","volume":"6","author":"JF Borel","year":"1976","unstructured":"Borel JF, Feuer C, Gubler HU, Stahelin H . Biological effects of cyclosporin A: a new antilymphocyte agent. Agents Actions 1976; 6: 468\u201375.","journal-title":"Agents Actions"},{"key":"BFeye1997126_CR3","first-page":"1323","volume":"ii","author":"RY Carne","year":"1978","unstructured":"Carne RY, Thiru S, McMaster P, Craddock GN, White DJG, Evans DB, et al. Cyclosporine A in patients receiving renal allografts from cadaveric donors. Lancet 1978; ii: 1323\u20137.","journal-title":"Lancet"},{"key":"BFeye1997126_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.iy.10.040192.002511","volume":"10","author":"NH Sigal","year":"1992","unstructured":"Sigal NH, Dumont FJ . Cyclosporin A, FK-506 and rapamycin: pharmacological probes of lymphocyte signal transduction. Annu Rev Immunol 1992; 10: 519\u201360.","journal-title":"Annu Rev Immunol"},{"key":"BFeye1997126_CR5","first-page":"1022","volume":"ii","author":"RY Carne","year":"1979","unstructured":"Carne RY, White DJG, Pentlow BD, Rolles K, Syrakos T, Ohtawa T, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases and 2 livers. Lancet 1979; ii: 1022\u201336.","journal-title":"Lancet"},{"key":"BFeye1997126_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1056\/NEJM198803173181103","volume":"318","author":"PF Bougneres","year":"1988","unstructured":"Bougneres PF, Carel JC, Castano L . Factors associated with early remission of type 1 diabetes in children treated with cyclosporine. N Engl J Med 1988; 318: 663\u201370.","journal-title":"N Engl J Med"},{"key":"BFeye1997126_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/art.1780300112","volume":"30","author":"O Forre","year":"1987","unstructured":"Forre O, Bjerkhoel F, Salvessen CF . An open, controlled, randomised comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: a preliminary report. Arthritis Rheum 1987; 30: 88\u201392.","journal-title":"Arthritis Rheum"},{"key":"BFeye1997126_CR8","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1172\/JCI110138","volume":"67","author":"RB Nussenblatt","year":"1981","unstructured":"Nussenblatt RB, Rodrigues MM, Wacker WB, Cevario SJ, Salinas-Carmona MC, Gery I . Cyclosporin A: inhibition of experimental autoimmune uveitis in rats. J Clin Invest 1981; 67: 1228\u201331.","journal-title":"J Clin Invest"},{"key":"BFeye1997126_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0140-6736(83)90230-1","volume":"ii","author":"RB Nussenblatt","year":"1983","unstructured":"Nussenblatt RB, Rook AH, Wacker WB, Palestine AG, Scher I, Gery I . Treatment of intraocular inflammatory disease with cyclosporin A. Lancet 1983; ii: 235\u20138.","journal-title":"Lancet"},{"key":"BFeye1997126_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/bjo.66.5.303","volume":"66","author":"TAG Bell","year":"1982","unstructured":"Bell TAG, Easty DL, McCullach KG . A placebo-controlled blind trial of cyclosporin-A in prevention of corneal graft rejection in rabbits. Br J Ophthalmol 1982; 66: 303\u20138.","journal-title":"Br J Ophthalmol"},{"key":"BFeye1997126_CR11","first-page":"686","volume":"22","author":"JC Kana","year":"1982","unstructured":"Kana JC, Hoffman F, Buchen R, Krolik A, Wiederholt M . Rabbit corneal allograft survival following topical administration of cyclosporin A. Invest Ophthalmol Vis Sci 1982; 22: 686\u201390.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1997126_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/00003226-199311000-00004","volume":"12","author":"J-C Zhao","year":"1993","unstructured":"Zhao J-C, Jin X-Y . Immunological analysis and treatment of Mooren's ulcer with cyclosporine A applied topically. Cornea 1993; 12: 481\u20138.","journal-title":"Cornea"},{"key":"BFeye1997126_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/0002-9394(89)90216-X","volume":"107","author":"D BenEzra","year":"1989","unstructured":"BenEzra D, Peter J, Brodsky M, Cohen E . Cyclosporine eye drops for the treatment of severe vernal keratoconjunctivitis. Am J Ophthalmol 1989; 107: 160\u20136.","journal-title":"Am J Ophthalmol"},{"key":"BFeye1997126_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/0002-9394(89)90216-X","volume":"107","author":"EJ Holland","year":"1989","unstructured":"Holland EJ, Chan C, Kuwabara T, Palestine AG, Rowseg IJ, Nussenblatt RB . Immunohistologic findings and results of treatment with cyclosporine in ligneous conjunctivitis. Am J Ophthalmol 1989; 107: 160\u20136.","journal-title":"Am J Ophthalmol"},{"key":"BFeye1997126_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S0002-9394(14)70704-4","volume":"109","author":"JT Liegner","year":"1990","unstructured":"Liegner JT, Yee RW, Wild JH . Topical cyclosporine therapy for ulcerative keratitis associated with rheumatoid arthritis. Am J Ophthalmol 1990; 109: 610\u20132.","journal-title":"Am J Ophthalmol"},{"key":"BFeye1997126_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/00003226-199309000-00008","volume":"12","author":"EJ Holland","year":"1993","unstructured":"Holland EJ, Olsen TW, Ketcham JM, Florine C, Krachmer JH, Purcell JJ, et al. Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea 1993; 12: 413\u20139.","journal-title":"Cornea"},{"key":"BFeye1997126_CR17","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1126\/science.2595372","volume":"246","author":"EA Emmel","year":"1989","unstructured":"Emmel EA, Vermeij CL, Durand DB, Higgins KM, Lacy E, Crabtree GR . Cyclosporine A specifically inhibits function of nuclear proteins involved in T cell activation. Science 1989; 246: 1617\u201320.","journal-title":"Science"},{"key":"BFeye1997126_CR18","first-page":"5074","volume":"11","author":"SS Banerji","year":"1991","unstructured":"Banerji SS, Parsons JN, Tocci MJ . The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the IL-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1. Mol Cell Biol 1991; 11: 5074\u201387.","journal-title":"Mol Cell Biol"},{"key":"BFeye1997126_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/0167-5699(93)90048-P","volume":"14","author":"J Liu","year":"1993","unstructured":"Liu J . FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol Today 1993; 14: 290\u20135.","journal-title":"Immunol Today"},{"key":"BFeye1997126_CR20","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1084\/jem.173.3.619","volume":"173","author":"NH Sigal","year":"1991","unstructured":"Sigal NH, Dumont F, Durette P, Sierkierka JJ, Peterson L, Rich D, et al. Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? J Exp Med 1991; 173: 619\u201328.","journal-title":"J Exp Med"},{"key":"BFeye1997126_CR21","doi-asserted-by":"publisher","first-page":"26431","DOI":"10.1016\/S0021-9258(18)47212-2","volume":"269","author":"NA Clipstone","year":"1994","unstructured":"Clipstone NA, Fiorentino DF, Crabtree GR . Molecular analysis of the interaction of calcineurin with drug\u2013immunophilin complexes. J Biol Chem 1994; 269: 26431\u20137.","journal-title":"J Biol Chem"},{"key":"BFeye1997126_CR22","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1016\/S0021-9258(18)53757-1","volume":"268","author":"PG McCaffrey","year":"1993","unstructured":"McCaffrey PG, Perino BA, Soderling TR, Rao A . NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. J Biol Chem 1993; 268: 3747\u201352.","journal-title":"J Biol Chem"},{"key":"BFeye1997126_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1126\/science.3749892","volume":"234","author":"SJ LeGrue","year":"1986","unstructured":"LeGrue SJ, Turner R, Weisbroth N, Dedman JR . Does the binding of cyclosporine to calmodulin result in immunosuppression? Science 1986; 234: 68\u201371.","journal-title":"Science"},{"key":"BFeye1997126_CR24","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/0006-2952(91)90257-6","volume":"42","author":"MJ Forrest","year":"1991","unstructured":"Forrest MJ, Jewell ME, Koo GC, Sigal NH . FK-506 and cyclosporine A: selective inhibition of calcium ionophore induced polymorphonuclear leucocyte degranulation. Biochem Biopharmacol 1991; 42: 1221\u20138.","journal-title":"Biochem Biopharmacol"},{"key":"BFeye1997126_CR25","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/339625a0","volume":"339","author":"YF Shi","year":"1989","unstructured":"Shi YF, Shahai BM, Green DR . Cyclosporin A inhibits activation-induced cell death in T cell hybridomas and thymocytes. Nature 1989; 339: 625\u20136.","journal-title":"Nature"},{"key":"BFeye1997126_CR26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2460\/ajvr.1984.45.01.112","volume":"45","author":"RL Kaswan","year":"1984","unstructured":"Kaswan RL, Martin CL, Chapman WL . Keratoconjunctivitis sicca: histopathological study of nictitating membrane and lacrimal glands from 28 canine cases. Am J Vet Res 1984; 45: 112\u20138.","journal-title":"Am J Vet Res"},{"key":"BFeye1997126_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0161-6420(88)33228-8","volume":"95","author":"R Wieczorek","year":"1988","unstructured":"Wieczorek R, Jakobiec FA, Sacks EH, Knowles DM . The immunoarchitecture of the normal human lacrimal gland: relevancy for understanding pathologic conditions. Ophthalmology 1988; 95: 100\u20139.","journal-title":"Ophthalmology"},{"key":"BFeye1997126_CR28","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1084\/jem.166.4.1198","volume":"166","author":"DA Jabs","year":"1987","unstructured":"Jabs DA, Prendergast RA . Reactive lymphocytes in lacrimal gland and vasculitic renal lesions of autoimmune MRL\/lpr mice express L3T4. J Exp Med 1987; 166: 1198\u2013203.","journal-title":"J Exp Med"},{"key":"BFeye1997126_CR29","first-page":"2035","volume":"35","author":"K Green","year":"1994","unstructured":"Green K, Palmer SL, Bowen PA . Systemic cyclosporine increases tear flow in renal allograft recipients. Invest Ophthalmol Vis Sci 1994; 35: 2035.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1997126_CR30","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/archopht.1989.01070020276038","volume":"107","author":"RL Kaswan","year":"1989","unstructured":"Kaswan RL, Salisbury MA, Ward DA . Spontaneous canine keratoconjunctivitis sicca: a useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops. Arch Ophthalmol 1989; 107: 1210\u20136.","journal-title":"Arch Ophthalmol"},{"key":"BFeye1997126_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.2042-3306.1994.tb04362.x","volume":"26","author":"L Reilly","year":"1994","unstructured":"Reilly L, Beech J . Bilateral keratoconjunctivitis in a horse. Eq Vet J 1994; 26: 171\u20132.","journal-title":"Eq Vet J"},{"key":"BFeye1997126_CR32","first-page":"61","volume":"4","author":"BK Collins","year":"1994","unstructured":"Collins BK, Johnson PJ, Moore CJ, Collier LL, Shaw MS . Immune-mediated keratoconjunctivitis sicca in a horse. Vet Comp Ophthalmol 1994; 4: 61\u20135.","journal-title":"Vet Comp Ophthalmol"},{"key":"BFeye1997126_CR33","first-page":"635","volume":"137","author":"DL Williams","year":"1995","unstructured":"Williams DL, Hoey A, Smitherman P . The use of topical cyclosporine and dexamethasone in the treatment of canine chronic superficial keratitis: a comparison of therapeutic effects. Vet Rec 1995; 137: 635\u20139.","journal-title":"Vet Rec"},{"key":"BFeye1997126_CR34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/356314a0","volume":"356","author":"R Watanbe-Fukunaga","year":"1992","unstructured":"Watanbe-Fukunaga R, Brannan CI, Copeland NG, Jenkins A, Nagata S . Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314\u20137.","journal-title":"Nature"},{"key":"BFeye1997126_CR35","first-page":"2632","volume":"35","author":"EH Sato","year":"1994","unstructured":"Sato EH, Sulivan DA . Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjogren' s syndrome. Invest Ophthalmol Vis Sci 1994; 35: 2632\u201342.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1997126_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/ard.46.2.89","volume":"46","author":"YA Dalavanga","year":"1987","unstructured":"Dalavanga YA, Detrick B, Hooks JJ, Drosos AA, Moutsopoulos HM . Effect of cyclosporin A (CsA) on the immunopathological lesion of the labial salivary glands from patients with primary Sjogren' s syndrome. Ann Rheum Dis 1987; 46: 89\u201392.","journal-title":"Ann Rheum Dis"},{"key":"BFeye1997126_CR37","first-page":"377","volume":"37","author":"DA Jabs","year":"1996","unstructured":"Jabs DA, Lee B, Burek CL, Saboori AM, Prendergast RA . Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL\/MP-lpr\/lpr mice. Invest Ophthalmol Vis Sci 1996; 37: 377\u201383.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1997126_CR38","first-page":"269","volume":"1","author":"PA Jackson","year":"1991","unstructured":"Jackson PA, Kaswan RL, Meredith RE, Barrett PM . Chronic superficial keratitis in dogs: a placebo controlled trial of topical cyclosporine treatment. Prog Vet Comp Ophthalmol 1991; 1: 269\u201375.","journal-title":"Prog Vet Comp Ophthalmol"},{"key":"BFeye1997126_CR39","first-page":"641","volume":"33","author":"AK Mircheff","year":"1992","unstructured":"Mircheff AK, Warren DW, Wood RL, Tortoriello PJ, Kaswan RL . Prolactin localisation, binding and effects on peroxidase release in rat exorbital lacrimal gland. Invest Ophthalmol Vis Sci 1992; 33: 641\u201350.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1997126_CR40","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/0006-291X(84)90762-9","volume":"121","author":"DH Russell","year":"1984","unstructured":"Russell DH, Matrisian L, Kibler R, Larson DF, Poulos R, Magun BE . Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochem Biophys Rev Commun 1984; 121: 899\u2013906.","journal-title":"Biochem Biophys Rev Commun"},{"key":"BFeye1997126_CR41","first-page":"46","volume":"31","author":"RL Kaswan","year":"1990","unstructured":"Kaswan RL, Salisbury MA, Mircheff AK, Glerow JP . Lacrimomimetic effects of cyclosporine. Invest Ophthalmol Vis Sci 1990; 31: 46.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1997126_CR42","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.4049\/jimmunol.134.5.3027","volume":"134","author":"DH Russell","year":"1985","unstructured":"Russell DH, Kibler R, Martrisian L, et al. Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol 1985; 134: 3027\u201331.","journal-title":"J Immunol"},{"key":"BFeye1997126_CR43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/0014-5793(94)01416-X","volume":"358","author":"S Wera","year":"1995","unstructured":"Wera S, Belayew A, Martial JA . Rapamycin, FK506 and cyclosporine A inhibit human prolactin gene expression. FEBS Lett 1995; 358: 158\u201360.","journal-title":"FEBS Lett"},{"key":"BFeye1997126_CR44","unstructured":"Weingarten AJ, Ballard F, Jaffe J, Schwartz HJ . Ocular absorption and penetration following topical application of a 2% ointment prepared with a solution of cyclosporine in corn oil. Proc Eur Assoc Vet Pharmacol Ther, Edinburgh, August 1994."},{"key":"BFeye1997126_CR45","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/bjo.73.8.600","volume":"73","author":"M Diaz-Llopis","year":"1988","unstructured":"Diaz-Llopis M, Menezo JL . Penetration of 2% cyclosporin eyedrops into human aqueous humour. Br J Ophthalmol 1988; 73: 600\u20133.","journal-title":"Br J Ophthalmol"},{"key":"BFeye1997126_CR46","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/bjo.70.11.852","volume":"70","author":"TAG Bell","year":"1986","unstructured":"Bell TAG, Hunnisett AG . Cyclosporine A: tissue levels following topical and systemic administration to rabbits. Br J Ophthalmol 1986; 70: 852\u20135.","journal-title":"Br J Ophthalmol"},{"key":"BFeye1997126_CR47","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1001\/archopht.1985.01050100135035","volume":"103","author":"RB Nussenblatt","year":"1985","unstructured":"Nussenblatt RB, Dinning WJ, Fujikawa LS, Chan C-C, Palestine AG . Local cyclosporine therapy for experimental autoimmune uveitis in rats. Arch Ophthalmol 1985; 103: 1559\u201362.","journal-title":"Arch Ophthalmol"},{"key":"BFeye1997126_CR48","first-page":"519","volume":"27","author":"M Wiederholt","year":"1986","unstructured":"Wiederholt M, Kossendrup D, Schultz W, Hoffmann F . Pharmacokinetics of topical cyclosporin A in the rabbit eye. Invest Ophthalmol Vis Sci 1986; 27: 519\u201324.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1997126_CR49","first-page":"650","volume":"20","author":"RL Kaswan","year":"1988","unstructured":"Kaswan RL . Intraocular penetration of topically applied cyclosporine. Transplant Proc 1988; 20: 650\u20135.","journal-title":"Transplant Proc"},{"key":"BFeye1997126_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/archopht.1985.01050010107030","volume":"103","author":"MW Mossteler","year":"1985","unstructured":"Mossteler MW, Gebbardt BM, Hamilton AM, Kaufman HE . Penetration of topical cyclosporine into the rabbit cornea, aqueous humour and serum. Arch Ophthalmol 1985; 103: 101\u20132.","journal-title":"Arch Ophthalmol"},{"key":"BFeye1997126_CR51","first-page":"114","volume":"20","author":"RB Nussenblatt","year":"1988","unstructured":"Nussenblatt RB . The use of cyclosporine in ocular inflammatory disorders. Transplant Proc 1988; 20: 114\u201321.","journal-title":"Transplant Proc"},{"key":"BFeye1997126_CR52","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/bjo.69.8.600","volume":"69","author":"B Foets","year":"1985","unstructured":"Foets B, Misoten L, Van der Veeren P, Goosens W . Prolonged survival of allogenic corneal grafts in rabbits treated with topically applied cyclosporin A: systemic absorption and local immunosuppressive effects. Br J Ophthalmol 1985; 69: 600\u20133.","journal-title":"Br J Ophthalmol"},{"key":"BFeye1997126_CR53","first-page":"2879","volume":"35","author":"H Saito","year":"1994","unstructured":"Saito H, Shimazaki J, Yang Y-H, Toda I, Fujishima H . Application of 0.05% cyclosporin A dissolved in alpha-cyclodextrin in human eyes. Invest Ophthalmol Vis Sci 1994; 35: 2879.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1997126_CR54","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/02713689408995775","volume":"13","author":"U Pleyer","year":"1994","unstructured":"Pleyer U, Elkins B, Rlicken D, Lutz S, Grammer J, Chou J, et al. Ocular absorption of cyclosporin A from liposomes incorporated into collagen shields. Curr Eye Res 1994; 13: 177\u201381.","journal-title":"Curr Eye Res"},{"key":"BFeye1997126_CR55","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1001\/archopht.1981.03930010599002","volume":"99","author":"OC Alldredge","year":"1981","unstructured":"Alldredge OC, Krachmer JH . Clinical types of corneal transplant rejection: their manifestations, frequency, preoperative correlates and treatment. Arch Ophthalmol 1981; 99: 599\u2013604.","journal-title":"Arch Ophthalmol"},{"key":"BFeye1997126_CR56","first-page":"686","volume":"22","author":"JS Kana","year":"1982","unstructured":"Kana JS, Hoffmann F, Buchen R, Krolik A, Wiederholt M . Rabbit corneal allograft survival following topical administration of cyclosporin A. Invest Ophthalmol Vis Sci 1982; 22: 686\u201390.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1997126_CR57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/bjo.64.3.148","volume":"64","author":"WFI Shepherd","year":"1980","unstructured":"Shepherd WFI, Coster DJ, Chin Fook T, Rice NSC, Jones BR . Effect of cyclosporin A on the survival of corneal grafts in rabbits. Br J Ophthalmol 1980; 64: 148\u201352.","journal-title":"Br J Ophthalmol"},{"key":"BFeye1997126_CR58","first-page":"173","volume":"45","author":"PA Hunter","year":"1981","unstructured":"Hunter PA, Wilhelmus KR, Rice NSC, Jones BR . Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection. Clin Exp Immunol 1981; 45: 173\u20139.","journal-title":"Clin Exp Immunol"},{"key":"BFeye1997126_CR59","first-page":"208","volume":"29","author":"C Newton","year":"1988","unstructured":"Newton C, Gebhardt BM, Kaufman HE . Topically applied cyclosporine in azone prolongs corneal allograft survival. Invest Ophthalmol Vis Sci 1988; 29: 208\u201315.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1997126_CR60","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0161-6420(93)31558-7","volume":"100","author":"JK Milani","year":"1993","unstructured":"Milani JK, Pleyer U, Dukes A, Chou HJ, Lutz S, R\u00fcckert D, Schmidt KH, Mondino BJ . Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye. Ophthalmology 1993; 100: 890\u20136.","journal-title":"Ophthalmology"},{"key":"BFeye1997126_CR61","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0161-6420(13)31253-6","volume":"101","author":"JC Hill","year":"1994","unstructured":"Hill JC . Systemic cyclosporine in high risk keratoplasty. Ophthalmology 1994; 101: 128\u201333.","journal-title":"Ophthalmology"},{"key":"BFeye1997126_CR62","first-page":"2016","volume":"35","author":"DL Williams","year":"1994","unstructured":"Williams DL . Histological and immunocytochemical analysis of canine chronic superficial keratitis. Invest Ophthalmol Vis Sci 1994; 35: 2016.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1997126_CR63","first-page":"267","volume":"1","author":"PA Jackson","year":"1991","unstructured":"Jackson PA, Kaswan RL, Meredith RE, Barrett PM . Chronic superficial keratitis in dogs: a placebo-controlled trial of topical cyclosporine treatment. Prog Vet Comp Ophthalmol 1991; 1: 267\u201376.","journal-title":"Prog Vet Comp Ophthalmol"},{"key":"BFeye1997126_CR64","doi-asserted-by":"publisher","first-page":"ll","DOI":"10.1136\/bjo.71.1.11","volume":"71","author":"JC Hill","year":"1987","unstructured":"Hill JC, Potter P . Treatment of Mooren's ulcer with cyclosporin A: a report of three cases. Br J Ophthalmol 1987; 71: ll\u20135.","journal-title":"Br J Ophthalmol"},{"key":"BFeye1997126_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF00162007","volume":"59","author":"PJ Kuit","year":"1985","unstructured":"Kuit PJ, Balen AThM, Stilma JS . Cyclosporin A in two cases of corneal peripheral melting syndrome. Doc Ophthalmol 1985; 59: 33\u20139.","journal-title":"Doc Ophthalmol"},{"key":"BFeye1997126_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00003226-198501000-00002","volume":"4","author":"F Hoffman","year":"1985","unstructured":"Hoffman F, Widerholt M . Local treatment of necrotising scleritis with cyclosporin A. Cornea 1985; 4: 3\u20137.","journal-title":"Cornea"},{"key":"BFeye1997126_CR67","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1748-5827.1995.tb02821.x","volume":"36","author":"RA Reed","year":"1995","unstructured":"Reed RA . Treatment of canine nictitans plasmacytic conjunctivitis with 0.2% cyclosporin ointment. J Small Anim Pract 1995; 36: 50\u20136.","journal-title":"J Small Anim Pract"},{"key":"BFeye1997126_CR68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2460\/javma.1988.192.01.73","volume":"192","author":"MB Glaze","year":"1988","unstructured":"Glaze MB, Crawford MA, Nachreiner RF, Casey HW, Nafe LA, Kearney MT . Ophthalmic corticosteroid therapy: systemic effects in the dog. J Am Vet Med Assoc 1988; 192: 73\u20135.","journal-title":"J Am Vet Med Assoc"},{"key":"BFeye1997126_CR69","unstructured":"Crispin SM . Personal communication."},{"key":"BFeye1997126_CR70","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/vr.137.7.170","volume":"137","author":"RA Reed","year":"1995","unstructured":"Reed RA, Barnett KC, Sansom J . Cyclosporin-responsive keratoconjunctivitis in the cat and horse. Vet Rec 1995; 137: 170\u2013l.","journal-title":"Vet Rec"},{"key":"BFeye1997126_CR71","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/S0161-6420(91)32069-4","volume":"98","author":"JH Bleik","year":"1991","unstructured":"Bleik JH, Tabbara KF . Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology 1991; 98: 1679\u201384.","journal-title":"Ophthalmology"},{"key":"BFeye1997126_CR72","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0091-6749(05)80120-4","volume":"86","author":"AM Irani","year":"1990","unstructured":"Irani AM, Butrus SI, Tabbara KF, Schwartz LB . Human conjunctival mast cells: distribution of MCr and MCrc in vernal conjunctivitis and giant papillary conjunctivitis. J Allergy Clin Immunol 1990; 86: 34\u201340.","journal-title":"J Allergy Clin Immunol"},{"key":"BFeye1997126_CR73","first-page":"3150","volume":"21","author":"A Kinai","year":"1989","unstructured":"Kinai A, Alba RM, Takano T, Kopnayashi C, Nakajima A, Kurihara K, et al. The effect on the cornea of alpha-cyclodextrin vehicle for cyclosporine eye drops. Transplant Proc 1989; 21: 3150\u20132.","journal-title":"Transplant Proc"},{"key":"BFeye1997126_CR74","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/00003226-199403000-00006","volume":"13","author":"JM Ben\u00edttez del Catillo","year":"1994","unstructured":"Ben\u00edttez del Catillo JM, del Aguila C, Duran S, Hernandez J, Sanchez JG . Influence of topically applied cyclosporin A in olive oil on corneal epithelial permeability. Cornea 1994; 13: 136\u201340.","journal-title":"Cornea"},{"key":"BFeye1997126_CR75","first-page":"1758","volume":"30","author":"MP Nasisse","year":"1989","unstructured":"Nasisse MP, Guy JS, Davidson MG, Susman WA, Fairley NM . Experimental ocular herpes virus infection in the cat. Invest Ophthalmol Vis Sci 1989; 30: 1758\u201368.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1997126_CR76","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1001\/archopht.1984.01040031462023","volume":"102","author":"HM Boisjoly","year":"1984","unstructured":"Boisjoly HM, Woog JJ, Pavan-Langston D, Oark NH . Prophylactic topical cyclosporine in experimental herpetic stromal keratitis. Arch Ophthalmol 1984; 102: 1804\u20137.","journal-title":"Arch Ophthalmol"},{"key":"BFeye1997126_CR77","first-page":"1170","volume":"28","author":"RH Meyers-Elliott","year":"1987","unstructured":"Meyers-Elliott RH, Chitjian PA, Billups CB . Effects of cyclosporine A on clinical and immunological parameters in herpes simplex keratitis. Invest Ophthalmol Vis Sci 1987; 28: 1170\u201380.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye1997126_CR78","doi-asserted-by":"crossref","first-page":"880","DOI":"10.2460\/ajvr.1995.56.07.880","volume":"56","author":"MAR Salisbury","year":"1995","unstructured":"Salisbury MAR, Kaswan RL, Brown J . Microorganisms isolated from the corneal surface before and during cyclosporine treatment in dogs with keratoconjunctivitis sicca. Am J Vet Res 1995; 56: 880\u20134.","journal-title":"Am J Vet Res"},{"key":"BFeye1997126_CR79","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1128\/AAC.24.6.921","volume":"24","author":"TN Kirland","year":"1983","unstructured":"Kirland TN, Fierer J . Cyclosporine A inhibits Cocci-diodes immitis in vitro and in vivo. Antimicrob Agents Chemother 1983; 24: 921\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"BFeye1997126_CR80","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1001\/archopht.1969.00990020012003","volume":"82","author":"OP van Bijsterveld","year":"1988","unstructured":"van Bijsterveld OP . Diagnostic tests in the sicca syndrome. Arch Ophthalmol 1988; 82: 10\u20134.","journal-title":"Arch Ophthalmol"},{"key":"BFeye1997126_CR81","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/00003226-199307000-00007","volume":"12","author":"RA Laibovitz","year":"1993","unstructured":"Laibovitz RA, Sotsh S, Andriano K, O'Connell M, Silverman MH . Pilot trial of cyclosporine 1% ophthalmic ointment in the treatment of keratoconjunctivitis sicca. Cornea 1993; 12: 315\u201323.","journal-title":"Cornea"},{"key":"BFeye1997126_CR82","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1755-3768.1994.tb02792.x","volume":"72","author":"K Gunduz","year":"1994","unstructured":"Gunduz K, Ozdemir O . Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjogren' s syndrome. Acta Ophthalmol (Copenh) 1994; 72: 438\u201342.","journal-title":"Acta Ophthalmol (Copenh)"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/eye1997126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/eye1997126","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/eye1997126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T22:01:20Z","timestamp":1741298480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye1997126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7,1]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,7,1]]}},"alternative-id":["BFeye1997126"],"URL":"https:\/\/doi.org\/10.1038\/eye.1997.126","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7,1]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}